Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: Lack of effect of ERK

Molecular and Cellular Biochemistry

Volumn 255, Issue 1-2, 2004, Pages 139-149

  Ceryak, Susan ^a   Zingariello, Carla ^a   O'Brien, Travis ^a   Patierno, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clonogenic survival; Hexavalent chronium; Mitogen activated protein kinase; Transcription

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHROMIUM; CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHORUS 32; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN P15; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; EXPOSURE; GENE EXPRESSION; GENE INDUCTION; GENE SEQUENCE; GENETIC STABILITY; GENOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; LUNG FIBROBLAST; MALIGNANT TRANSFORMATION; MITOSIS INHIBITION; REVIEW; RIBONUCLEASE PROTECTION ASSAY; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION;

APOPTOSIS; CARCINOGENS, ENVIRONMENTAL; CHILD; CHROMIUM; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, CDC; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA, MESSENGER;

EID: 0345061267     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000007270.82431.3e     Document Type: Review

References (54)

1. Hayes RB: Review of occupational epidemiology of chromium chemicals and respiratory cancer. Science Total Environ 71: 331-339, 1988
2. Langard S: One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am J Ind Med 17: 189-215, 1990
3. International Agency for Research on Cancer: Chromium, nickel and welding. In: IARC. Monographs on the Evaluation of the Carcinogenic Risk to Humans, Vol. 49. Lyon, 1990, pp 1-648
4. De Flora S: Threshold mechanisms and site specificity in chromium (VI) carcinogenesis. Carcinogenesis 21: 533-541, 2000
5. Miller CA III, Costa M: Characterization of DNA-protein complexes induced in intact cells by the carcinogen chromate. Mol Carcinogen 1: 125-133, 1988
6. Standeven AM, Wetterhahn KE: Chromium (VI) toxicity: Uptake, reduction, and DNA damage. J Am Cell Toxicol 8: 1275-1283, 1989
7. Singh J, Mclean JA, Pritchard DE, Montaser A, Patierno SR: Sensitive quantitation of chromium-DNA adducts by inductively coupled plasma mass spectrometry with a direct injection high-efficiency nebulizer. Toxicol Sci 46: 260-265, 1998
8. Xu J, Manning FC, Patierno SR: Preferential formation and repair of chromium-induced DNA adducts and DNA-protein crosslinks in nuclear matrix DNA. Carcinogenesis 15: 1443-1450, 1994
9. Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR: Chromium (VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17: 1511-1517, 1996
10. Singh J, Bridgewater LC, Patierno SR: Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA. Toxicol Sci 45: 72-76, 1998
11. Bridgewater LC, Manning FC, Patierno SR: Base-specific arrest of in vitro DNA replication by carcinogenic chromium: Relationship to DNA interstrand crosslinking. Carcinogenesis 15: 2421-2427, 1994
12. Singh J, Carlisle DL, Pritchard DE, Patierno SR: Chromium-induced genotoxicity and apoptosis: Relationship to chromium carcinogenesis (review). Oncol Rep 5: 1307-1318, 1998
13. Bridgewater LC, Manning FC, Woo ES, Patierno SR: DNA polymerase arrest by adducted trivalent chromium. Mol Carcinogen 9: 122-133, 1994
14. Manning FC, Xu J, Patierno SR: Transcriptional inhibition by carcinogenic chromate: Relationship to DNA damage. Mol Carcinogen 6: 270-279, 1992
15. Patierno SR, Banh D, Landolph JR: Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res 48: 5280-5288, 1988
16. Patierno SR, Landolph JR: Soluble vs. insoluble hexavalent chromate. Relationship of mutation to in vitro transformation and particle uptake. Biol Trace Element Res 21: 469-474, 1989
17. Zhitkovich A, Song Y, Quievryn G, Voitkun V: Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: Role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40: 549-560, 2001
18. Tully DB, Collins BJ, Overstreet JD, Smith CS, Dinse GE, Mumtaz MM, Chapin RE: Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol Appl Pharmacol 168: 79-90, 2000
19. Wetterhahn KE, Hamilton JW: Molecular basis of hexavalent chromium carcinogenicity: Effect on gene expression. Sci Total Environ 86: 113-129, 1989
20. Hamilton JW, Kaltreider RC, Bajenova OV, Ihnat MA, McCaffrey J, Turpie BW, Rowell EE, Oh J, Nemeth MJ, Pesce CA, Lariviere JP: Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ Health Perspect 106 (suppl 4): 1005-1015, 1998
21. Singh J, Pritchard DE, Carlisle DL, Mclean JA, Montaser A, Orenstein JM, Patierno SR: Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: Formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol Appl Pharmacol 161: 240-248, 1999
22. Wise JP Sr, Stearns DM, Wetterhahn KE, Patierno SR: Cell-enhanced dissolution of carcinogenic lead chromate particles: The role of individual dissolution products in clastogenesis. Carcinogenesis 15: 2249-2254, 1994
23. Flatt PM, Polyak K, Tang LJ, Scatena CD, Westfall MD, Rubinstein LA, Yu J, Kinzler KW, Vogelstein B, Hill DE, Pietenpol JA: p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett 156: 63-72, 2000
24. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997
25. Carlisle DL, Pritchard DE, Singh J, Patierno SR: Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol Carcinogen 28: 111-118, 2000
26. Carlisle DL, Pritchard DE, Singh J, Owens BM, Blankenship LJ, Orenstein JM, Patierno SR: Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): Effect of ascorbate and tocopherol. Toxicol Sci 55: 60-68, 2000
27. Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonini J, Ding M, Rojanasakul Y, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J Biol Chem 274: 34974-34980, 1999
28. Wang S, Shi X: Mechanisms of Cr(VI)-induced p53 activation: The role of phosphorylation, mdm2 and ERK. Carcinogenesis 22: 757-762, 2001
29. Ha L, Ceryak S, Patierno SR: Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein: Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J Biol Chem 278: 17885-17894, 2003
30. Ballif BA, Blenis J: Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12: 397-408, 2001
31. Thomas G: MAP kinase by any other name smells just as sweet. Cell 68: 3-6, 1992
32. Rivard N, Boucher MJ, Asselin C, L'Allemain G: MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am J Physiol 277: C652-C664, 1999
33. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ: ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 277: 12710-12717, 2002
34. Persons DL, Yazlovitskaya EM, Cui W, Pelling JC: Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res 5: 1007-1014, 1999
35. Buckley S, Driscoll B, Barsky L, Weinberg K, Anderson K, Warburton D: ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am J Physiol 277: L159-L166, 1999
36. DeHaan RD, Yazlovitskaya EM, Persons DL: Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase. Cancer Chemother Pharmacol 48: 383-388, 2001
37. Chuang SM, Liou GY, Yang JL: Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 21: 1491-1500, 2000
38. Pritchard DE, Ceryak S, Ha L, Fornsaglio JL, Hartman SK, O'Brien TJ, Patierno SR: Mechanism of apoptosis and determination of cellular fate in chromium(VI)-exposed populations of telomerase-immortalized human fibroblasts. Cell Growth Differ 2001
39. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679, 1998
40. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995
41. Ye J, Shi X: Gene expression profile in response to chromium-induced cell stress in A549 cells. Mol Cell Biochem 222: 189-197, 2001
42. Pritchard DE, Singh J, Carlisle DL, Patierno SR: Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis 21: 2027-2033, 2000
43. Korsmeyer SJ, Gross A, Harada H, Zha J, Wang K, Yin XM, Wei M, Zinkel S: Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. Cold Spring Harb Symp Quant Biol 64: 343-350, 1999
44. Nicolli A, Basso E, Petronilli V, Wenger RM, Bernardi P: Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem 271: 2185-2192, 1996
45. O'Brien TJ, Fornsaglio JL, Ceryak S, Patierno SR: Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. DNA Rep 1: 617-627, 2002
46. Sionov RV, Haupt Y: The cellular response to p53: The decision between life and death. Oncogene 18: 6145-6157, 1999
47. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677, 1998
48. Saito S, Goodarzi AA, Higashimoto Y, Noda Y, Lees-Miller SP, Appella E, Anderson CW: ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J Biol Chem 277: 12491-12494, 2002
49. Persons DL, Yazlovitskaya EM, Pelling JC: Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem 275: 35778-35785, 2000
50. Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y: Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res 60: 5988-5994, 2000
51. Hayakawa J, Ohmichi M, Kurachi H, Ikegami H, Kimura A, Matsuoka T, Jikihara H, Mercola D, Murata Y: Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J Biol Chem 274: 31648-31654, 1999
52. Greulich H, Erikson RL: An analysis of Mek1 signaling in cell proliferation and transformation. J Biol Chem 273: 13280-13288, 1998
53. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M: Regulation of Raf-Akt Cross-talk. J Biol Chem 277: 31099-31106, 2002
54. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J: Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4: 556-564, 2002